Moneycontrol PRO
HomeNewsAarti pharmalabs

Aarti Pharmalabs

Jump to
  • AARTIPHARM Consolidated September 2025 Net Sales at Rs 418.33 crore, down 8.67% Y-o-Y

  • AARTIPHARM Standalone September 2025 Net Sales at Rs 417.29 crore, up 10.6% Y-o-Y

    AARTIPHARM Standalone September 2025 Net Sales at Rs 417.29 crore, up 10.6% Y-o-Y

  • Stocks to Watch Today: Lupin, TechD Cybersecurity, PNC Infratech, Netweb Tech, Garden Reach, Redington, Power Grid, Amber Enterprises in focus on 22 September

    Stocks to Watch Today: Lupin, TechD Cybersecurity, PNC Infratech, Netweb Tech, Garden Reach, Redington, Power Grid, Amber Enterprises in focus on 22 September

    Stocks to Watch, 22 September: Stocks like PNC Infratech, Lupin, TechD Cybersecurity, Netweb Technologies, Garden Reach Shipbuilders, Redington, Power Grid Corporation of India, and Amber Enterprises India will be in focus on September 22.

  • Promoter sells 0.66% stake in Aarti Pharmalabs; Norges Bank, Vanguard Group pick 1.7% shares for Rs 145.8 crore

    Promoter sells 0.66% stake in Aarti Pharmalabs; Norges Bank, Vanguard Group pick 1.7% shares for Rs 145.8 crore

    Aarti Pharmalabs shares rallied 3.3 percent to Rs 930.2 amid significant volumes on the NSE.

  • AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y

    AARTIPHARM Standalone March 2025 Net Sales at Rs 529.62 crore, up 27.68% Y-o-Y

  • AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y

    AARTIPHARM Consolidated March 2025 Net Sales at Rs 563.78 crore, up 11.47% Y-o-Y

  • Trade Spotlight: How should you trade SRF, Berger Paints, Narayana Hrudayalaya, SBI Card, Bajaj Finance, and others on February 28?

    Trade Spotlight: How should you trade SRF, Berger Paints, Narayana Hrudayalaya, SBI Card, Bajaj Finance, and others on February 28?

    The consolidation is expected to continue until the indices decisively break the range of the last three days on either side. Below are some trading ideas for the near term.

  • Trade Spotlight: How should you trade Tata Motors, BHEL, Bajaj Finserv, Apollo Tyres, Aarti Pharmalabs, and others on February 18?

    Trade Spotlight: How should you trade Tata Motors, BHEL, Bajaj Finserv, Apollo Tyres, Aarti Pharmalabs, and others on February 18?

    The market may extend the upward move amid consolidation, but sustainability will be key to watch. Below are some trading ideas for the near term.

  • AARTIPHARM Consolidated December 2024 Net Sales at Rs 537.78 crore, up 19.86% Y-o-Y

    AARTIPHARM Consolidated December 2024 Net Sales at Rs 537.78 crore, up 19.86% Y-o-Y

  • AARTIPHARM Standalone December 2024 Net Sales at Rs 470.95 crore, up 26.25% Y-o-Y

    AARTIPHARM Standalone December 2024 Net Sales at Rs 470.95 crore, up 26.25% Y-o-Y

  • IndusInd Bank, Aarti Pharmalabs, Gensol Engineering, Power Mech Projects | Stocks on Radar

    IndusInd Bank, Aarti Pharmalabs, Gensol Engineering, Power Mech Projects | Stocks on Radar

    IndusInd Bank: The private sector lender is selling its MFI retail loan pool worth Rs 1,573 crore on a 100% cash basis to improve liquidity and optimize its balance sheet. Aarti Pharmalabs: Abakkus Asset Manager, led by ace investor Sunil Singhania, buys a 1.18% stake in Aarti Pharmalabs for Rs 61.52 crore, while promoters sell 1.1% stake for Rs 57.5 crore. Gensol Engineering: Secures a contract worth Rs 897.47 crore from NTPC Renewable Energy to develop 225MW solar PV projects in Gujarat. Power Mech Projects: Bags an order worth Rs 186 crore from Jaiprakash Power Ventures to provide operation and maintenance services for Jaypee Nigrie Super Thermal Power Plant. Jubilant FoodWorks: Signs an MoU with Coca-Cola India to buy its portfolio of sparkling beverage products and certain other products, also undertaking marketing activities.

  • Stocks to Watch Today: DAM Capital, Transrail Lighting, Mamata Machinery, Gensol, Power Mech, SKF India, Aarti Pharmalabs in focus on 27 December

    Stocks to Watch Today: DAM Capital, Transrail Lighting, Mamata Machinery, Gensol, Power Mech, SKF India, Aarti Pharmalabs in focus on 27 December

    Stocks To Watch Today, Dec 27: Stocks like IndusInd Bank, Gensol Engineering, NHPC, Gujarat Fluorochemicals, HMA Agro Industries, Dixon Technologies, RBL Bank, Dhani Services, Lemon Tree Hotels, EPACK Durable, One Mobikwik Systems, SG Mart, Sanathan Textiles, and Concord Enviro Systems will also be in focus on December 27.

  • AARTIPHARM Consolidated September 2024 Net Sales at Rs 458.03 crore, up 4.14% Y-o-Y

    AARTIPHARM Consolidated September 2024 Net Sales at Rs 458.03 crore, up 4.14% Y-o-Y

  • AARTIPHARM Standalone September 2024 Net Sales at Rs 377.29 crore, up 5.94% Y-o-Y

    AARTIPHARM Standalone September 2024 Net Sales at Rs 377.29 crore, up 5.94% Y-o-Y

  • AARTIPHARM Consolidated June 2024 Net Sales at Rs 555.49 crore, up 21.19% Y-o-Y

    AARTIPHARM Consolidated June 2024 Net Sales at Rs 555.49 crore, up 21.19% Y-o-Y

  • AARTIPHARM Standalone June 2024 Net Sales at Rs 393.49 crore, up 9.87% Y-o-Y

    AARTIPHARM Standalone June 2024 Net Sales at Rs 393.49 crore, up 9.87% Y-o-Y

  • Stock Radar: Power Grid, Nykaa, Gland Pharma, Go Digit, Granules India in focus on Thursday

    Stock Radar: Power Grid, Nykaa, Gland Pharma, Go Digit, Granules India in focus on Thursday

    ITC, InterGlobe Aviation, Honasa Consumer, Bayer Cropscience, Cello World, CESC, Concord Biotech, Finolex Cables, Page Industries, Tata Investment Corporation, and Zaggle Prepaid Ocean Services will release March quarter earnings on May 23.

  • Bulk deals: Quant MF buys 1.1% stake in Aarti Pharmalabs

    Bulk deals: Quant MF buys 1.1% stake in Aarti Pharmalabs

    Baron Emerging Markets Fund sold a 0.95 percent stake in Aarti Pharmalabs Limited.

  • AARTIPHARM Standalone March 2024 Net Sales at Rs 414.82 crore, up 10.83% Y-o-Y

    AARTIPHARM Standalone March 2024 Net Sales at Rs 414.82 crore, up 10.83% Y-o-Y

  • AARTIPHARM Consolidated December 2023 Net Sales at Rs 448.69 crore, down 69.27% Y-o-Y

    AARTIPHARM Consolidated December 2023 Net Sales at Rs 448.69 crore, down 69.27% Y-o-Y

  • AARTIPHARM Standalone December 2023 Net Sales at Rs 373.03 crore, down 67.19% Y-o-Y

    AARTIPHARM Standalone December 2023 Net Sales at Rs 373.03 crore, down 67.19% Y-o-Y

  • AARTIPHARM Standalone March 2023 Net Sales at Rs 374.27 crore, up 2.62% Y-o-Y

    AARTIPHARM Standalone March 2023 Net Sales at Rs 374.27 crore, up 2.62% Y-o-Y

  • AARTIPHARM Consolidated March 2023 Net Sales at Rs 485.06 crore, up 5.38% Y-o-Y

    AARTIPHARM Consolidated March 2023 Net Sales at Rs 485.06 crore, up 5.38% Y-o-Y

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347